Advicenne Pharma
Clinical trials sponsored by Advicenne Pharma, explained in plain language.
-
Kidney acidosis drug trial pulled before starting
Disease control TerminatedThis study aimed to test the long-term safety and effectiveness of ADV7103 in people with a rare kidney condition called primary distal renal tubular acidosis, which causes acid buildup in the blood. The trial planned to include adults, children, and infants, but was withdrawn be…
Phase: PHASE3 • Sponsor: Advicenne Pharma • Aim: Disease control
Last updated May 26, 2026 11:37 UTC
-
Promising cystinuria drug study halted before it began
Disease control TerminatedThis study planned to test a drug called ADV7103 for people with cystinuria, a condition that causes painful kidney stones. The goal was to see if the drug could raise urine pH to prevent stones from forming. The study was withdrawn before any patients were enrolled, so no result…
Phase: PHASE2, PHASE3 • Sponsor: Advicenne Pharma • Aim: Disease control
Last updated May 20, 2026 11:54 UTC